216 related articles for article (PubMed ID: 18327029)
1. Modern methods to predict costs for the treatment and management of head and neck cancer patients: examples of methods used in the current literature.
Wineland AM; Stack BC
Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):113-6. PubMed ID: 18327029
[TBL] [Abstract][Full Text] [Related]
2. Using comorbidity indexes to predict costs for head and neck cancer.
Hollenbeak CS; Stack BC; Daley SM; Piccirillo JF
Arch Otolaryngol Head Neck Surg; 2007 Jan; 133(1):24-7. PubMed ID: 17224517
[TBL] [Abstract][Full Text] [Related]
3. The economics of squamous cell carcinoma of the head and neck.
Menzin J; Lines LM; Manning LN
Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):68-73. PubMed ID: 17413405
[TBL] [Abstract][Full Text] [Related]
4. The clinician's expectations from the use of positron emission tomography/computed tomography scanning in untreated and treated head and neck cancer patients.
Fleming AJ; Johansen ME
Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):127-34. PubMed ID: 18327031
[TBL] [Abstract][Full Text] [Related]
5. The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare data.
Lang K; Menzin J; Earle CC; Jacobson J; Hsu MA
Arch Otolaryngol Head Neck Surg; 2004 Nov; 130(11):1269-75. PubMed ID: 15545580
[TBL] [Abstract][Full Text] [Related]
6. Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck.
Lang K; Sussman M; Friedman M; Su J; Kan HJ; Mauro D; Tafesse E; Menzin J
Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):582-8. PubMed ID: 19528407
[TBL] [Abstract][Full Text] [Related]
7. Effect of comorbidity on post-treatment quality of life scores in patients with head and neck squamous cell carcinoma.
Gourin CG; Boyce BJ; Vaught CC; Burkhead LM; Podolsky RH
Laryngoscope; 2009 May; 119(5):907-14. PubMed ID: 19358195
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center.
Nonzee NJ; Dandade NA; Patel U; Markossian T; Agulnik M; Argiris A; Patel JD; Kern RC; Munshi HG; Calhoun EA; Bennett CL
Cancer; 2008 Sep; 113(6):1446-52. PubMed ID: 18683883
[TBL] [Abstract][Full Text] [Related]
9. PET monitoring of therapy response in head and neck squamous cell carcinoma.
Schöder H; Fury M; Lee N; Kraus D
J Nucl Med; 2009 May; 50 Suppl 1():74S-88S. PubMed ID: 19380408
[TBL] [Abstract][Full Text] [Related]
10. A multidisciplinary approach to squamous cell carcinomas of the head and neck: what is new?
Licitra L; Bossi P; Locati LD
Curr Opin Oncol; 2006 May; 18(3):253-7. PubMed ID: 16552237
[TBL] [Abstract][Full Text] [Related]
11. Integration of prospective quality of life and nutritional assessment as routine components of multidisciplinary care of patients with head and neck cancer.
Oates J; Clark JR; Read J; Reeves N; Gao K; O'Brien CJ
ANZ J Surg; 2008; 78(1-2):34-41. PubMed ID: 18199203
[TBL] [Abstract][Full Text] [Related]
12. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.
Malone JP; Gerberi MA; Vasireddy S; Hughes LF; Rao K; Shevlin B; Kuhn M; Collette D; Tennenhouse J; Robbins KT
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1119-25. PubMed ID: 19917925
[TBL] [Abstract][Full Text] [Related]
13. American Society of Clinical Oncology guidance statement: the cost of cancer care.
Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
[TBL] [Abstract][Full Text] [Related]
14. Additional direct medical costs associated with nosocomial infections after head and neck cancer surgery: a hospital-perspective analysis.
Penel N; Lefebvre JL; Cazin JL; Clisant S; Neu JC; Dervaux B; Yazdanpanah Y
Int J Oral Maxillofac Surg; 2008 Feb; 37(2):135-9. PubMed ID: 18022348
[TBL] [Abstract][Full Text] [Related]
15. Esophageal cancers with synchronous or antecedent head and neck cancers: a more formidable challenge?
Lo OS; Law S; Wei WI; Ng WM; Wong KH; Tong KH; Wong J
Ann Surg Oncol; 2008 Jun; 15(6):1750-6. PubMed ID: 18347873
[TBL] [Abstract][Full Text] [Related]
16. Advances in quality of life and symptom management for head and neck cancer patients.
Murphy BA
Curr Opin Oncol; 2009 May; 21(3):242-7. PubMed ID: 19322081
[TBL] [Abstract][Full Text] [Related]
17. Higher distress relates to poor quality of life in patients with head and neck cancer.
Pandey M; Devi N; Ramdas K; Krishnan R; Kumar V
Int J Oral Maxillofac Surg; 2009 Sep; 38(9):955-9. PubMed ID: 19446438
[TBL] [Abstract][Full Text] [Related]
18. Recent changes in the epidemiology of head and neck cancer.
Curado MP; Hashibe M
Curr Opin Oncol; 2009 May; 21(3):194-200. PubMed ID: 19363341
[TBL] [Abstract][Full Text] [Related]
19. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
[TBL] [Abstract][Full Text] [Related]
20. Implementing the National Institute of Clinical Excellence improving outcome guidelines for head and neck cancer: developing a business plan with reorganisation of head and neck cancer services.
Jeannon JP; Abbs I; Calman F; Gleeson M; Lyons A; Hussain K; McGurk M; O'Connell M; Probert D; Ng R; Simo R
Clin Otolaryngol; 2008 Apr; 33(2):149-51. PubMed ID: 18429872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
